110383 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV; Use of virus, viral particle or viral elements as a vector Special targeting system for viral vectors
LIPID PARTICLES COMPRISING VARIANT PARAMYXOVIRUS ATTACHMENT GLYCOPROTEINS AND USES THEREOF
#2VARIANTS OF COAGULATION FACTOR VIII AND USES THEREOF
#3LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#4LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#5Retroviral and Lentiviral Vectors
#6CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOF
#7ANTI-CD90 ANTIBODIES, BINDING FRAGMENTS, AND USES THEREOF
#8CYTOKINE RECEPTOR AGONIST AND VIRAL VECTOR COMBINATION THERAPIES
#9LIGAND DISCOVERY AND GENE DELIVERY VIA RETROVIRAL SURFACE DISPLAY
#10LENTIVIRAL GENE THERAPY RESCUES FUNCTION IN A MOUSE MODEL OF USHER 1B
#11CELL-TYPE SPECIFIC MEMBRANE FUSION PROTEINS
#12ENGINEERED VIRAL PARTICLES AND USES OF THE SAME
#13EBOLA PSEUDOTYPED VECTORS AND METHODS OF USE THEREOF
#14Methods and Compositions for the Labeling and Selection of Antigen-Specific T-Cells
#15RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF
#16Ligand discovery and gene delivery via retroviral surface display
#17ENGINEERING HEMAGGLUTININ AND FUSION POLYPEPTIDES OF CANINE DISTEMPER VIRUS
#18COMPOSITIONS AND METHODS FOR USING ALTERNATIVE SPLICING TO CONTROL SPECIFICITY OF GENE THERAPY
#19Retroviral And Lentiviral Vectors
#20Ligand discovery and gene delivery via retroviral surface display
#21Biliary Delivery Methods, Compositions and Kits for Use Therein
#22VIRAL DELIVERY OF GAS VESICLE GENES
#23A PROMOTER SPECIFIC FOR NON-PIGMENTED CILIARY EPITHELIAL CELLS
#24CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#25VIRAL TARGETING OF HEMATOPOIETIC STEM CELLS
#26VECTORS AND COMPOSITIONS FOR TREATING HEMOGLOBINOPATHIES
#27Retroviral and lentiviral vectors
#28Ligand discovery and gene delivery via retroviral surface display
#29CD25 PRE-SELECTIVE COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE
#30Vectors and compositions for treating hemoglobinopathies
#31SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS
#32Packaging cell for making a pseudotyped lentivirus
#33Retroviral and lentiviral vectors
#34VIRAL VECTOR NANOCAPSULE FOR TARGETING GENE THERAPY AND ITS PREPARATION
#35Gene vector
#36Method for inducing CCR5Δ32 deletion by using CRISPR-Cas9 genome editing technique
#37System comprising a nucleotide sequence encoding a volvox carteri light-activated ion channel protein (VCHR1)
#38REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS
#39Methods of delivering a pseudotyped lentivirus
#40Retroviral and lentiviral vectors
#41GLUT-1 AS A RECEPTOR FOR HTLV ENVELOPES AND ITS USES
#42Methods and compositions relating to improved lentiviral vectors and their applications
#43System utilizing light-activated ion channel protein (VChR1) for optical stimulation of target cells
#44Lentiviral vectors
#45Methods and compositions for inhibiting retinopathy of prematurity
#46Methods and compositions relating to improved lentiviral vectors and their applications
#47Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#48Pseudotyped lentiviral vectors
#49Method for producing enveloped viruses
#50Viral vector nanocapsule for targeting gene therapy and its preparation
#51Methods for treating parkinson's disease by optically stimulating target cells
#52Method of stimulating an immune response using a pseudotyped lentivirus
#53Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein
#54Gene vector
#55Vector for the selective silencing of a gene in astrocytes
#56GLUT-1 as a receptor for HTLV envelopes and its uses
#57Expression vector comprising a nucleotide sequence encoding a light-activated ion channel protein (VChR1) and implantable device thereof
#58Mammalian Cell Culture System for Large-Scale Expression of Recombinant Proteins
#59Lentiviral vectors pseudotyped with mutant BaEV glycoproteins
#60Chimeric glycoproteins and pseudotyped lentiviral vectors
#61Determination of in vivo DNA double-strand break localization and application thereof
#62Methods and compositions relating to improved lentiviral vectors and their applications
#63Baculoviruses with enhanced virion production and a method for the production of baculoviruses
#64Targeted gene delivery to dendritic cells
#65Systems, methods and compositions for optical stimulation of target cells
#66Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#67Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#68TREATMENT OF PAIN THROUGH EXPRESSION OF OPIOID RECEPTORS
#69REPEATED ADMINISTRATION OF LENTIVIRAL VECTORS TO RESPIRATORY CELLS
#70GLUT-1 as a receptor for HTLV envelopes and its uses
#71Gene vector
#72Methods and compositions relating to improved lentiviral vectors and their applications
#73Therapeutic agents for diseases associated with apoptotic degeneration in ocular tissue cells that use SIV-PEDF vectors
#74GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#75METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES
#76Methods and compositions for targeted integration
#77Compositions and methods for studying and treating inflammatory diseases and disorders
#78TRANSGENIC ORGANISM
#79Glut-1 as a receptor for HTLV envelopes and its uses
#80Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#81Vector system
#82Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins
#83Targeted gene delivery for dendritic cell vaccination
#84Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#85Vectors
#86Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
#87Chimeric glycoproteins and pseudotyped lentiviral vectors
#88CAEV-based vector systems
#89Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase
#90Retroviral delivery system
#91Pseudotyped retrovirus with modified ebola glycoprotein
#92Retinoic acid receptor beta-2, its agonists, and gene therapy vectors for the treatment of neurological disorders
#93Vector packaging cell line
#94Methods for producing and using pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#95Delivery system
#96Pseudotyped viruses and methods for their use
#97Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)
#98Methods for producing and using in vivo pseudotyped retroviruses
#99Paramyxoviruses as gene transfer vectors to lung cells